• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies.

作者信息

Meggendorfer Manja, Cappelli Luca Vincenzo, Walter Wencke, Haferlach Claudia, Kern Wolfgang, Falini Brunangelo, Haferlach Torsten

机构信息

MLL Munich Leukemia Laboratory, Munich, Germany.

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.

出版信息

Leukemia. 2018 May;32(5):1249-1253. doi: 10.1038/s41375-018-0026-z. Epub 2018 Jan 30.

DOI:10.1038/s41375-018-0026-z
PMID:29568090
Abstract
摘要

相似文献

1
IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies.急性髓系白血病中的异柠檬酸脱氢酶1（IDH1）第132位密码子突变、异柠檬酸脱氢酶2（IDH2）第140位密码子突变和IDH2第172位密码子突变：不同的基因格局与预后相关，并可能影响靶向治疗策略。
Leukemia. 2018 May;32(5):1249-1253. doi: 10.1038/s41375-018-0026-z. Epub 2018 Jan 30.
2
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis.IDH2R140 和 IDH2R172 突变对急性髓系白血病患者的预后价值：系统评价和荟萃分析。
BMC Cancer. 2023 Jun 9;23(1):527. doi: 10.1186/s12885-023-11034-7.
3
(2,3)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia.（2,3）-二羟基丁酸合成作为急性髓系白血病中突变型异柠檬酸脱氢酶1和2的一种新代谢功能
Cancers (Basel). 2020 Oct 1;12(10):2842. doi: 10.3390/cancers12102842.
4
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.强化治疗的 IDH 突变型 AML 患者同时存在基因突变的预后意义：ALFA 研究。
Blood. 2021 May 20;137(20):2827-2837. doi: 10.1182/blood.2020010165.
5
Therapeutic targeting of isocitrate dehydrogenase mutant AML.异柠檬酸脱氢酶突变型急性髓系白血病的治疗靶点
Expert Opin Investig Drugs. 2017 May;26(5):525-530. doi: 10.1080/13543784.2017.1317745. Epub 2017 Apr 19.
6
Novel Therapeutics in Acute Myeloid Leukemia.急性髓系白血病的新型疗法
Am Soc Clin Oncol Educ Book. 2017;37:495-503. doi: 10.1200/EDBK_175401.
7
Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicin.在接受高剂量阿糖胞苷和伊达比星治疗的 AML 患者中，IDH 酶同工酶改变的预后意义。
Cancer. 2012 May 15;118(10):2665-73. doi: 10.1002/cncr.26580. Epub 2011 Oct 21.
8
Deep Sequencing of Acute Myeloid Leukemia Reveals Driver Mutations and New Targets.急性髓系白血病的深度测序揭示驱动突变和新靶点。
J Natl Cancer Inst. 2016 Feb 9;108(2). doi: 10.1093/jnci/djw018. Print 2016 Feb.
9
Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.全基因组整合分析鉴定 IDH2 R140Q 突变型急性髓系白血病潜在的分子机制和治疗靶点。
Oncol Rep. 2019 May;41(5):2876-2888. doi: 10.3892/or.2019.7075. Epub 2019 Mar 18.
10
Inhibition of mutant IDH1 in acute myeloid leukaemia.急性髓系白血病中突变型异柠檬酸脱氢酶1的抑制作用
Lancet Oncol. 2015 Jan;16(1):e9. doi: 10.1016/S1470-2045(14)71140-4. Epub 2014 Nov 28.

引用本文的文献

1
Mutant cooperates with or to drive distinct myeloid diseases and molecular outcomes.突变体协同或驱动不同的髓系疾病及分子结果。
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2415779122. doi: 10.1073/pnas.2415779122. Epub 2025 May 16.
2
Rare Genetic and Uncommon Morphological Entities in Adults with Acute Myeloid Leukemia.成人急性髓系白血病中的罕见遗传和不常见形态学实体
Curr Oncol Rep. 2025 Apr 28. doi: 10.1007/s11912-025-01678-y.
3
Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.
患有急性髓系白血病（AML）且存在异柠檬酸脱氢酶2（IDH2）R172突变的患者对强化化疗诱导呈现出独特的初始反应。
Blood Adv. 2025 Jul 8;9(13):3213-3222. doi: 10.1182/bloodadvances.2024015324.
4
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.急性髓系白血病异基因移植前可测量的残留突变型异柠檬酸脱氢酶1
Bone Marrow Transplant. 2025 Feb;60(2):154-160. doi: 10.1038/s41409-024-02447-4. Epub 2024 Nov 6.
5
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.急性髓系白血病异基因移植前可测量的残留突变型异柠檬酸脱氢酶2
Bone Marrow Transplant. 2025 Feb;60(2):144-153. doi: 10.1038/s41409-024-02449-2. Epub 2024 Oct 25.
6
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT.异柠檬酸脱氢酶（IDH）1 和 2 突变可预测行异基因造血细胞移植的急性髓系白血病患者的更好结局：来自 EBMT 的 ALWP 的研究。
Bone Marrow Transplant. 2024 Nov;59(11):1534-1541. doi: 10.1038/s41409-024-02384-2. Epub 2024 Aug 14.
7
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets.骨髓增生异常肿瘤中缺失 7 和 7q 的基因组学：从致病元凶到潜在的合成致死治疗靶点。
Leukemia. 2023 Oct;37(10):2082-2093. doi: 10.1038/s41375-023-02003-x. Epub 2023 Aug 26.
8
Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias.NPM1突变型急性髓系白血病的遗传、表型及临床异质性
Biomedicines. 2023 Jun 24;11(7):1805. doi: 10.3390/biomedicines11071805.
9
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis.IDH2R140 和 IDH2R172 突变对急性髓系白血病患者的预后价值：系统评价和荟萃分析。
BMC Cancer. 2023 Jun 9;23(1):527. doi: 10.1186/s12885-023-11034-7.
10
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.IDH 突变在 AML 中的特征和预后影响：COG、SWOG 和 ECOG 分析。
Blood Adv. 2023 Oct 10;7(19):5941-5953. doi: 10.1182/bloodadvances.2022008282.